ESR1 and cancer: Although beyond the scope of this review, it is important to note that ER negative breast cancer cells can later revert back to ER positive cancer following trastuzumab and chemotherapy treatment, except for triple negative breast cancers [46], and putative estrogen receptor positive breast cancer stem cells have been identified [47].